Literature DB >> 15778373

Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3.

Hans-Ingo Trompeter1, Natalia Gómez-Lozano, Simeon Santourlidis, Britta Eisermann, Peter Wernet, Carlos Vilches, Markus Uhrberg.   

Abstract

The generation of killer cell Ig-like receptor (KIR) expression patterns in NK cells involves variegated silencing of KIR genes by DNA methylation. To identify regulatory elements involved in KIR gene activation, upstream regions of KIR genes were functionally characterized in NK3.3 cells as well as in primary NK cells. Three kinds of KIR promoters were defined, controlling clonally expressed KIR genes, the constitutively active KIR2DL4, and the weakly expressed KIR3DL3. Upstream of a short core promoter common to all KIR genes, a region containing functionally divergent elements was characterized. Although this region had no impact on the activity of the KIR2DL3 promoter, an inhibitory element was identified in the KIR2DL4 promoter and an activating element was found in the KIR3DL3 promoter. Upon treatment with a methyltransferase inhibitor, KIR3DL3 expression could be readily induced showing that the low levels of KIR3DL3 expression in peripheral blood are due to sustained DNA methylation of an otherwise fully functional promoter. Analysis of transcription factor binding sites identified a functional acute myeloid leukemia (AML) site common to all three KIR promoters. Mutation of this site led to a substantial increase in activity of all KIR promoters. Among the different members of the AML family, AML-2 was identified as the predominant KIR binding factor. The present study suggests that AML-2 acts as a repressor of KIR expression in mature NK cells and opens the possibility that AML factors and associated cofactors are involved in regulation of KIR expression during NK cell development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778373     DOI: 10.4049/jimmunol.174.7.4135

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR.

Authors:  Jeroen van Bergen; Frits Koning
Journal:  Immunology       Date:  2010-08-17       Impact factor: 7.397

2.  Promoter variants of KIR2DL5 add to diversity and may impact gene expression.

Authors:  Tiernan J Mulrooney; LiHua Hou; Noriko K Steiner; Minghua Chen; Ian Belle; Jennifer Ng; Carolyn Katovich Hurley
Journal:  Immunogenetics       Date:  2008-05-07       Impact factor: 2.846

3.  KIR2DL4 genetic diversity in a Brazilian population sample: implications for transcription regulation and protein diversity in samples with different ancestry backgrounds.

Authors:  Emiliana Weiss; Heloisa S Andrade; Juliana Rodrigues Lara; Andreia S Souza; Michelle A Paz; Thálitta H A Lima; Iane O P Porto; Nayane S B Silva; Camila F Bannwart Castro; Rejane M T Grotto; Eduardo A Donadi; Celso T Mendes-Junior; Erick C Castelli
Journal:  Immunogenetics       Date:  2021-02-17       Impact factor: 2.846

4.  A small, variable, and irregular killer cell Ig-like receptor locus accompanies the absence of MHC-C and MHC-G in gibbons.

Authors:  Laurent Abi-Rached; Heiner Kuhl; Christian Roos; Boudewijn ten Hallers; Baoli Zhu; Lucia Carbone; Pieter J de Jong; Alan R Mootnick; Florian Knaust; Richard Reinhardt; Peter Parham; Lutz Walter
Journal:  J Immunol       Date:  2009-12-21       Impact factor: 5.422

5.  KIR2DS2 and KIR2DS4 promoter hypomethylation patterns in patients undergoing hematopoietic cell transplantation (HCT).

Authors:  Ghislaine M Gallez-Hawkins; Xiuli Li; Anne E Franck; Ketevan Gendzekhadze; Ryotaro Nakamura; Stephen J Forman; David Senitzer; John A Zaia
Journal:  Hum Immunol       Date:  2012-08-30       Impact factor: 2.850

6.  The transcription factor c-Myc enhances KIR gene transcription through direct binding to an upstream distal promoter element.

Authors:  Frank Cichocki; Rebecca J Hanson; Todd Lenvik; Michelle Pitt; Valarie McCullar; Hongchuan Li; Stephen K Anderson; Jeffrey S Miller
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

7.  A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature.

Authors:  Sarah Cooley; Feng Xiao; Michelle Pitt; Michelle Gleason; Valarie McCullar; Tracy L Bergemann; Karina L McQueen; Lisbeth A Guethlein; Peter Parham; Jeffrey S Miller
Journal:  Blood       Date:  2007-03-28       Impact factor: 22.113

8.  Effects of activating NK cell receptor expression and NK cell reconstitution on the outcomes of unrelated donor hematopoietic cell transplantation for hematologic malignancies.

Authors:  B M Triplett; E M Horwitz; R Iyengar; V Turner; M S Holladay; K Gan; F G Behm; W Leung
Journal:  Leukemia       Date:  2009-02-12       Impact factor: 11.528

9.  Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.

Authors:  Karina L McQueen; Kristel M Dorighi; Lisbeth A Guethlein; Ruby Wong; Bharati Sanjanwala; Peter Parham
Journal:  Hum Immunol       Date:  2007-03-12       Impact factor: 2.850

10.  KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection.

Authors:  Michiko Taniguchi; Masato Kawabata
Journal:  Immunogenetics       Date:  2010-01-05       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.